Benitec Biopharma Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Benitec Biopharma Inc. is publicly traded on NASDAQ under the ticker BNTC.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the...
Can you invest in Benitec Biopharma Inc.?
Yes. Benitec Biopharma Inc. is publicly traded on NASDAQ under the ticker BNTC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Benitec Biopharma Inc.
Detailed equity research is provided by MarketSnap.